Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 4/2013

01-04-2013 | Original Article

PET/MR imaging of the pelvis in the presence of endoprostheses: reducing image artifacts and increasing accuracy through inpainting

Authors: Claes Nøhr Ladefoged, Flemming Littrup Andersen, Sune Høgild Keller, Johan Löfgren, Adam Espe Hansen, Søren Holm, Liselotte Højgaard, Thomas Beyer

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 4/2013

Login to get access

Abstract

Purpose

In combined whole-body PET/MR, attenuation correction (AC) is performed indirectly using the available MR image information and subsequent segmentation. Implant-induced susceptibility artifacts and subsequent signal voids may challenge MR-based AC (MR-AC). We evaluated the accuracy of MR-AC in PET/MR in patients with metallic endoprostheses, and propose a clinically feasible correction method.

Methods

We selected patients with uni- or bilateral endoprostheses from 61 consecutive referrals for whole-body PET/MR imaging (mMR; Siemens Healthcare). Simultaneous whole-body PET/MR imaging was performed at 120 min after injection of about 300 MBq [18F]FDG. MR-AC was performed using (1) original MR images and subsequent Dixon water–fat segmentation, (2) as method 1 with implant-induced signal voids filled with soft tissue, (3) as method 2 with superimposed coregistered endoprostheses from the CT scan, and (4) as method 1 with implant-induced signal voids filled with metal. Following MR-AC (methods 1–4) PET emission images were reconstructed on 344 × 344 matrices using attenuation-weighted OSEM (three iterations, 21 subsets, 4 mm gaussian). Maximum body-weight normalized standardized uptake values (SUVmax) were obtained for both hips. Mean SUV (SUVmean) in homogeneous reference regions in the gluteal muscle and bladder following MR-AC (methods 1–4) are also reported.

Results

In total, four patients presented with endoprostheses, unilateral in two and bilateral in two. The fraction of voxels in MR images affected by the implant was at least twice that of the voxels representing the actual implants. MR-AC using methods 2 and 3 recovered the FDG distribution pattern compared to uncorrected PET images and method 1, while method 4 resulted in severe overestimation of FDG uptake (>460 % SUVmax). When compared to method 1, relative changes in SUVmean in the reference regions from method 2 and 3 were generally small albeit not correlated with the fraction of the attenuation image affected by implant-induced artifacts.

Conclusions

Endoprostheses cause PET/MR artifacts that exceed the volume occupied by the implants, and bias PET quantification. Artifacts and bias can be corrected by semiautomated inpainting with soft tissue with a single composition prior to MR-AC, thus restoring quantitative activity distribution.
Literature
1.
go back to reference Hillner B, Siegel B, Liu D, Shields AF, Gareen IF, Hanna L, et al. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol. 2008;26:2155–61.PubMedCrossRef Hillner B, Siegel B, Liu D, Shields AF, Gareen IF, Hanna L, et al. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol. 2008;26:2155–61.PubMedCrossRef
2.
go back to reference Zhuang H, Alavi A. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47–59.PubMedCrossRef Zhuang H, Alavi A. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47–59.PubMedCrossRef
3.
go back to reference Haroon A, Zumla A, Bomanji J. Role of fluorine 18 fluorodeoxyglucose positron emission tomography-computed tomography in focal and generalized infectious and inflammatory disorders. Clin Infect Dis. 2012;54:1333–41.PubMedCrossRef Haroon A, Zumla A, Bomanji J. Role of fluorine 18 fluorodeoxyglucose positron emission tomography-computed tomography in focal and generalized infectious and inflammatory disorders. Clin Infect Dis. 2012;54:1333–41.PubMedCrossRef
4.
go back to reference Mumme T, Reinartz P, Cremerius U, Hermanns B, Müller-Rath R, Neuss M, et al. [F-18]-fluorodeoxyglucose (FDG) positron emission tomography (PET) as a diagnostic for hip endoprosthesis loosening. Z Orthop Ihre Grenzgeb. 2003;141:540–6.PubMedCrossRef Mumme T, Reinartz P, Cremerius U, Hermanns B, Müller-Rath R, Neuss M, et al. [F-18]-fluorodeoxyglucose (FDG) positron emission tomography (PET) as a diagnostic for hip endoprosthesis loosening. Z Orthop Ihre Grenzgeb. 2003;141:540–6.PubMedCrossRef
5.
go back to reference Mayer-Wagner S, Mayer W, Maegerlein S, Linke R, Jansson V, Müller PE. Use of 18F-FDG-PET in the diagnosis of endoprosthetic loosening of knee and hip implants. Arch Orthop Trauma Surg. 2010;130:1231–8.PubMedCrossRef Mayer-Wagner S, Mayer W, Maegerlein S, Linke R, Jansson V, Müller PE. Use of 18F-FDG-PET in the diagnosis of endoprosthetic loosening of knee and hip implants. Arch Orthop Trauma Surg. 2010;130:1231–8.PubMedCrossRef
6.
go back to reference Beyer T, Freudenberg L, Czernin J, Townsend DW. The future of hybrid imaging – part 3: PET/MR, small animal imaging and beyond. Insights Imaging. 2011;2:235–46.PubMedCrossRef Beyer T, Freudenberg L, Czernin J, Townsend DW. The future of hybrid imaging – part 3: PET/MR, small animal imaging and beyond. Insights Imaging. 2011;2:235–46.PubMedCrossRef
7.
go back to reference Beyer T, Freudenberg L, Townsend DW, Czernin J. The future of hybrid imaging – part 1: hybrid imaging technologies and SPECT/CT. Insights Imaging. 2011;2:161–9.PubMedCrossRef Beyer T, Freudenberg L, Townsend DW, Czernin J. The future of hybrid imaging – part 1: hybrid imaging technologies and SPECT/CT. Insights Imaging. 2011;2:161–9.PubMedCrossRef
8.
go back to reference Beyer T, Townsend D, Czernin J, Freudenberg LS. The future of hybrid imaging – part 2: PET/CT. Insights Imaging. 2011;2:225–34.PubMedCrossRef Beyer T, Townsend D, Czernin J, Freudenberg LS. The future of hybrid imaging – part 2: PET/CT. Insights Imaging. 2011;2:225–34.PubMedCrossRef
9.
go back to reference Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR. “Anatometabolic” tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med. 1993;34:1190–7.PubMed Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR. “Anatometabolic” tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med. 1993;34:1190–7.PubMed
10.
go back to reference Kinahan P, Hasegawa B, Beyer T. X-ray based attenuation correction for PET/CT scanners. Semin Nucl Med. 2003;33:166–79.PubMedCrossRef Kinahan P, Hasegawa B, Beyer T. X-ray based attenuation correction for PET/CT scanners. Semin Nucl Med. 2003;33:166–79.PubMedCrossRef
11.
go back to reference Pichler B, Kolb A, Nägele T, Schlemmer HP. PET/MRI: paving the way for the next generation of clinical multimodality imaging applications. J Nucl Med. 2010;51:333–6.PubMedCrossRef Pichler B, Kolb A, Nägele T, Schlemmer HP. PET/MRI: paving the way for the next generation of clinical multimodality imaging applications. J Nucl Med. 2010;51:333–6.PubMedCrossRef
12.
go back to reference Hofmann M, Pichler B, Schölkopf B, Beyer T. Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques. Eur J Nucl Med Mol Imaging. 2009;36 Suppl 1:S93–104.PubMedCrossRef Hofmann M, Pichler B, Schölkopf B, Beyer T. Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques. Eur J Nucl Med Mol Imaging. 2009;36 Suppl 1:S93–104.PubMedCrossRef
13.
go back to reference Boellaard R, O’Doherty M, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37:181–200.PubMedCrossRef Boellaard R, O’Doherty M, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37:181–200.PubMedCrossRef
14.
go back to reference Brix G, Lechel U, Glatting G, Ziegler SI, Münzing W, Müller SP, et al. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. J Nucl Med. 2005;46:608–13.PubMed Brix G, Lechel U, Glatting G, Ziegler SI, Münzing W, Müller SP, et al. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. J Nucl Med. 2005;46:608–13.PubMed
15.
go back to reference Cahir J, Toms AP. CT and MRI of hip replacements. Orthop Traumatol. 2009;23:101–8. Cahir J, Toms AP. CT and MRI of hip replacements. Orthop Traumatol. 2009;23:101–8.
16.
go back to reference Kinahan PE, Townsend DW, Beyer T, Sashin D. Attenuation correction for a combined 3D PET/CT scanner. Med Phys. 1998;25:2046–53.PubMedCrossRef Kinahan PE, Townsend DW, Beyer T, Sashin D. Attenuation correction for a combined 3D PET/CT scanner. Med Phys. 1998;25:2046–53.PubMedCrossRef
17.
go back to reference Kalemis A, Delattre B, Heinzer S. Sequential whole-body PET/MR scanner: concept, clinical use and optimisations after two years in the clinic. The manufacturer’s perspective. MAGMA. 2012. doi:10.1007/s10334-012-0330-y.PubMed Kalemis A, Delattre B, Heinzer S. Sequential whole-body PET/MR scanner: concept, clinical use and optimisations after two years in the clinic. The manufacturer’s perspective. MAGMA. 2012. doi:10.​1007/​s10334-012-0330-y.PubMed
18.
go back to reference Delso G, Fürst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med. 2011;52:1914–22.PubMedCrossRef Delso G, Fürst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med. 2011;52:1914–22.PubMedCrossRef
19.
go back to reference Martinez-Möller A, Souvatzoglou M, Delso G, Bundschuh RA, Chefd'hotel C, Ziegler SI, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med. 2009;50:520–6.PubMedCrossRef Martinez-Möller A, Souvatzoglou M, Delso G, Bundschuh RA, Chefd'hotel C, Ziegler SI, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med. 2009;50:520–6.PubMedCrossRef
20.
go back to reference Ramos-Cabrer P, van Duynhoven JP, Van der Toorn A, Nicolay K. MRI of hip prostheses using single-point methods: in vitro studies towards the artifact-free imaging of individuals with metal implants. Magn Reson Imaging. 2004;22:1097–103.PubMedCrossRef Ramos-Cabrer P, van Duynhoven JP, Van der Toorn A, Nicolay K. MRI of hip prostheses using single-point methods: in vitro studies towards the artifact-free imaging of individuals with metal implants. Magn Reson Imaging. 2004;22:1097–103.PubMedCrossRef
21.
go back to reference Pauchard Y, Smith MR, Mintchev MP. Improving geometric accuracy in the presence of susceptibility difference artifacts produced by metallic implants in magnetic resonance imaging. IEEE Trans Med Imaging. 2005;24:1387–99.PubMedCrossRef Pauchard Y, Smith MR, Mintchev MP. Improving geometric accuracy in the presence of susceptibility difference artifacts produced by metallic implants in magnetic resonance imaging. IEEE Trans Med Imaging. 2005;24:1387–99.PubMedCrossRef
22.
go back to reference Reft C, Alecu R, Das IJ, Gerbi BJ, Keall P, Lief E, et al. Dosimetric considerations for patients with HIP prostheses undergoing pelvic irradiation. Report of the AAPM Radiation Therapy Committee Task Group 63. Med Phys. 2003;30:1162–82.PubMedCrossRef Reft C, Alecu R, Das IJ, Gerbi BJ, Keall P, Lief E, et al. Dosimetric considerations for patients with HIP prostheses undergoing pelvic irradiation. Report of the AAPM Radiation Therapy Committee Task Group 63. Med Phys. 2003;30:1162–82.PubMedCrossRef
24.
go back to reference Joemai RM, de Bruin PW, Veldkamp WJ, Geleijns J. Metal artifact reduction for CT: development, implementation, and clinical comparison of a generic and a scanner-specific technique. Med Phys. 2012;39:1125–32.PubMedCrossRef Joemai RM, de Bruin PW, Veldkamp WJ, Geleijns J. Metal artifact reduction for CT: development, implementation, and clinical comparison of a generic and a scanner-specific technique. Med Phys. 2012;39:1125–32.PubMedCrossRef
25.
go back to reference Meyer E, Raupach R, Lell M, Schmidt B, Kachelrieß M. Frequency split metal artifact reduction (FSMAR) in computed tomography. Med Phys. 2012;39:1904–16.PubMedCrossRef Meyer E, Raupach R, Lell M, Schmidt B, Kachelrieß M. Frequency split metal artifact reduction (FSMAR) in computed tomography. Med Phys. 2012;39:1904–16.PubMedCrossRef
26.
go back to reference Schäfers K, Raupach R, Beyer T. Combined 18F-FDG-PET/CT imaging of the head and neck. An approach to metal artifact correction. Nuklearmedizin. 2006;45:219–22.PubMed Schäfers K, Raupach R, Beyer T. Combined 18F-FDG-PET/CT imaging of the head and neck. An approach to metal artifact correction. Nuklearmedizin. 2006;45:219–22.PubMed
Metadata
Title
PET/MR imaging of the pelvis in the presence of endoprostheses: reducing image artifacts and increasing accuracy through inpainting
Authors
Claes Nøhr Ladefoged
Flemming Littrup Andersen
Sune Høgild Keller
Johan Löfgren
Adam Espe Hansen
Søren Holm
Liselotte Højgaard
Thomas Beyer
Publication date
01-04-2013
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 4/2013
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-012-2316-4

Other articles of this Issue 4/2013

European Journal of Nuclear Medicine and Molecular Imaging 4/2013 Go to the issue